EP 3606941 B1 20240501 - NOVEL DEPSIPEPTIDES AND USES THEREOF
Title (en)
NOVEL DEPSIPEPTIDES AND USES THEREOF
Title (de)
NEUARTIGE DEPSIPEPTIDE UND VERWENDUNGEN DAVON
Title (fr)
NOUVEAUX DEPSIPEPTIDES ET LEURS UTILISATIONS
Publication
Application
Priority
- US 201762481412 P 20170404
- US 2018025365 W 20180330
Abstract (en)
[origin: WO2018187173A1] The present invention relates generally to novel depsipeptides, to methods for the preparation of the novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
IPC 8 full level
C07K 11/02 (2006.01); A61K 38/00 (2006.01); C07K 7/06 (2006.01); C07K 7/56 (2006.01)
CPC (source: EP US)
A61P 31/04 (2018.01 - EP US); C07K 7/06 (2013.01 - EP); C07K 7/56 (2013.01 - EP); C07K 11/02 (2013.01 - EP US); C12N 1/20 (2013.01 - US); A61K 38/00 (2013.01 - US); Y02A 50/30 (2018.01 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2018187173 A1 20181011; AU 2018249453 A1 20191031; AU 2018249453 B2 20220707; CA 3057987 A1 20181011; CN 110612306 A 20191224; CN 110612306 B 20240507; CN 118271402 A 20240702; EP 3606941 A1 20200212; EP 3606941 B1 20240501; JP 2020515623 A 20200528; JP 7194115 B2 20221221; US 11203616 B2 20211221; US 11891415 B2 20240206; US 2020031871 A1 20200130; US 2022185845 A1 20220616
DOCDB simple family (application)
US 2018025365 W 20180330; AU 2018249453 A 20180330; CA 3057987 A 20180330; CN 201880030453 A 20180330; CN 202410478383 A 20180330; EP 18719001 A 20180330; JP 2019554527 A 20180330; US 201816500470 A 20180330; US 202117524230 A 20211111